Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-11-27Clinical Trial Update: DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing Gastric Cancer [DESTINY-Gastric01] [Phase 2]
Phase 2 trial Destiny-Gastric01 evaluating DS-8201a (trastuuzumab deruxtecan) in HER2-expressing gastric cancer has completed with posted re…
-
CLINICAL_TRIALS trial_result · 2020-11-17Clinical Trial Update: Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma [Phase 2]
Phase 2 trial evaluating conversion therapy with Camrelizumab plus chemoradiotherapy in patients with initially unresectable gastric or GEJ …
-
CLINICAL_TRIALS trial_result · 2020-11-10Clinical Trial Update: Efficacy and Safety of Apatinib Combined With S-1 for Patients With Advance Gastric Cancer [Phase 2]
Phase 2 clinical trial update evaluating the efficacy and safety of apatinib combined with S-1 for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2020-10-26Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific Markers [Phase 2]
Phase 2 clinical trial evaluating toripalimab for recurrent or metastatic gastric or gastroesophageal junction adenocarcinoma after failure …
-
CLINICAL_TRIALS trial_result · 2020-10-23Clinical Trial Update: Chemotherapy Options for the First Line Chemotherapy in Elderly Patient With Advanced Gastric Cancer [Phase 3]
Phase 3 clinical trial updating first-line chemotherapy options for elderly patients with advanced gastric cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Chemotherapy and Radiation Therapy in Treating Patients With Stomach Cancer [Phase 2]
A Phase 2 clinical trial evaluating chemotherapy and radiation therapy in patients with gastric cancer has been completed.
-
CLINICAL_TRIALS trial_result · 2020-10-12Clinical Trial Update: Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers [EARLY_Phase 1]
Early-phase trial evaluating postoperative chemoradiation or chemotherapy after preoperative chemotherapy for gastric cancers; study termina…
-
CLINICAL_TRIALS trial_result · 2020-10-01Clinical Trial Update: Camrelizumab Combined With Apatinib Mesylate Tablets and Nab-paclitaxel in the Second-line Treatment of Advanced Gastric Cancer [Phase 1, Phase 2]
Clinical trial evaluating camrelizumab plus apatinib and nab-paclitaxel for second-line advanced gastric cancer (Phase 1/2).
-
CLINICAL_TRIALS trial_result · 2020-09-28Clinical Trial Update: Safety and Efficacy Study for MG-7-DC Vaccine in Gastric Cancer Treatment [Phase 1, Phase 2]
A clinical trial update for MG-7-DC vaccine in gastric cancer spanning Phase 1 and Phase 2 to assess safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Andecaliximab Combined With Nivolumab Versus Nivolumab Alone in Adults With Unresectable or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
Phase 2 trial evaluating andecaliximab with nivolumab vs nivolumab alone in unresectable or recurrent gastric or gastroesophageal junction a…
-
CLINICAL_TRIALS trial_result · 2020-09-18Clinical Trial Update: Phase 2 Study of KH903 in Patients With Advanced Gastric or Gastroesophageal Junction Adenocarcinoma As Second-Line Therapy [Phase 2]
Phase 2 study update for KH903 in advanced gastric or gastroesophageal junction adenocarcinoma as second-line therapy; status not disclosed.
-
FDA approval · 2020-09-10FDA Approved: DOCETAXEL — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for a generic docetaxel product (docetaxel anhydrous) from Mylan Institutional LLC.
-
CLINICAL_TRIALS trial_result · 2020-08-24Clinical Trial Update: Pegliposomal Doxorubicin and 5-fluorouracil as Second Line Therapy for Metastatic Gastric Cancer [Phase 2]
Clinical trial update for pegyliposomal doxorubicin and 5-fluorouracil as second-line therapy in metastatic gastric cancer (Phase 2).
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer [Phase 3]
Phase 3 trial evaluating vaccine therapy in combination with chemotherapy for metastatic or locally recurrent stomach and esophageal cancers…
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus or Stomach [Phase 2]
Phase 2 clinical trial evaluating irinotecan and paclitaxel in metastatic or recurrent esophageal or gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2020-08-03Clinical Trial Update: Irinotecan in Treating Patients With Esophageal or Stomach Cancer [Phase 2]
Phase 2 clinical trial investigating irinotecan in esophageal and gastric cancer has completed.
-
CLINICAL_TRIALS research · 2020-07-31Clinical Trial Update: Effects of Ilaprazole on Ulcer Healing Rate and Prevention of Gastrointestinal Bleeding in the Patients Undergone ESD. [Phase 4]
A Phase 4 trial evaluating ilaprazole for ulcer healing and prevention of gastrointestinal bleeding after endoscopic submucosal dissection i…
-
CLINICAL_TRIALS trial_result · 2020-07-23Clinical Trial Update: Tisseel® as a Reinforcement of Esophagojejunal Anastomoses [Phase 4]
Phase 4 clinical trial evaluating Tisseel as reinforcement of esophagojejunal anastomoses in gastric cancer patients to reduce anastomotic l…
-
FDA approval · 2020-06-29FDA Approved: PHESGO — Original Application (Genentech, Inc.)
FDA approved PHESGO (PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF) from Genentech under an Original Application; a fixed-dose subcutaneou…
-
CLINICAL_TRIALS trial_result · 2020-06-22Clinical Trial Update: Dragon III: Neoadjuvant Chemotherapy (FLOT Versus SOX) for Gastric Cancer [Phase 2]
Phase 2 trial Dragon III compares neoadjuvant FLOT versus SOX in gastric cancer; results were posted after completion.
-
CLINICAL_TRIALS trial_result · 2020-06-17Clinical Trial Update: A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer. [Phase 2, Phase 3]
A clinical trial comparing QL1604 plus nab-paclitaxel versus nab-paclitaxel alone in advanced gastric or gastroesophageal junction adenocarc…
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Gastric Tissue Stapler Comparison Study
A completed clinical trial comparing gastric tissue staplers in gastric resection procedures; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-06-01Clinical Trial Update: Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC) [Phase 1, Phase 2]
A clinical trial update for neoadjuvant chemotherapy with PISOXO in locally invaded gastric cancer spanning Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2020-05-22Clinical Trial Update: The Impact of Enhanced Recovery After Surgery (ERAS) Program on Clinical and Immunological Outcomes for Minimally-invasive Gastrectomy [Phase 3]
Phase 3 clinical trial evaluating how an Enhanced Recovery After Surgery (ERAS) program affects clinical and immunological outcomes after mi…
-
CLINICAL_TRIALS trial_result · 2020-05-15Clinical Trial Update: FOLFOX Plus Regorafenib in Patients With Unresectable or Metastatic Esophagogastric Cancer [Phase 2]
A Phase 2 trial evaluating FOLFOX plus regorafenib in unresectable or metastatic esophagogastric cancer has completed with results posted in…